H-1B filings

Does Revance Therapeutics, Inc. sponsor H-1B?

Yes, according to public filings. Revance Therapeutics, Inc. filed 32 H-1B labor condition applications in fiscal years 2024-2026, including 4 in fiscal year 2026.

USCIS approved 24 H-1B petitions for this employer in fiscal years 2024-2026.

This page uses public government filings. A filing does not guarantee that the employer will sponsor you. This information is not legal advice.

Status on October 22, 2026: USCIS does not collect the $100,000 payment on new H-1B petitions for workers outside the U.S. while court orders stand. Appeals are pending, so this can change. USCIS H-1B FAQ

Labor condition applications by fiscal year

Fiscal yearFiledCertifiedWorkers
2026444
2025121212
2024161515

An employer files a labor condition application with the Department of Labor before it files an H-1B petition. A certified application is not an approved visa. The U.S. fiscal year runs from October 1 to September 30.

USCIS decisions on H-1B petitions by fiscal year

Fiscal yearNew: approvedNew: deniedContinuing: approvedContinuing: denied
20262030
20250080
202410100

New petitions are for first H-1B employment. Continuing petitions are for extensions and for workers who change employers.

Typical roles and wage ranges

Job titleApplicationsWage range per yearMedian
Senior Data Engineer, IT Commercial3$150,000 - $156,000$150,000
Sr. Specialist, Quality Assurance2$145,000 - $145,000$145,000
Scientist, Process Development2$141,100 - $141,100$141,100
Csv Engineer2$128,000 - $128,000$128,000
Devops Engineer2$155,000 - $170,331$170,331
Senior Systems Administrator2$110,000 - $111,000$111,000
Facilities Engineer2$115,000 - $115,000$115,000
Technical Lead, Full Stack Engineer2$150,000 - $150,000$150,000
Quality Control Analyst II, Analytical1$100,053 - $100,053$100,053
Data Engineer, IT Commercial1$114,566 - $114,566$114,566

Wages are the rates the employer stated in its applications. Actual pay can differ.

Top locations

Sources

Data release 2026q3, built on October 23, 2026.